Literature DB >> 26847804

Recurrent cerebral ischaemic events in the setting of paroxysmal nocturnal haemoglobinuria.

Luísa Azevedo1, Mariana Reis Costa1, Ana Catarina Fonseca1, Teresa Pinho e Melo1.   

Abstract

The authors present a case of a 28-year-old man with a known history of paroxysmal nocturnal haemoglobinuria (PNH), under platelet antiaggregation, admitted following recurrent transitory arterial ischaemic attacks. Concomitant thrombosis of the superior mesenteric artery and bilateral renal infarction was found. Cardioembolism, namely patent foramen ovale, was excluded and anticoagulation added, with no further events on 10-month follow-up. PNH is a rare acquired disorder of haematopoietic stem cells, characterised by haemolytic anaemia, pancytopenia and thrombotic events classically involving the venous system. Reports of cerebral artery stroke and accompanying intra-abdominal arterial thrombosis are especially rare. Complementary investigation and treatment options in these patients are discussed. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26847804      PMCID: PMC4746544          DOI: 10.1136/bcr-2015-213603

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria.

Authors:  S T A Van Bijnen; W L Van Heerde; P Muus
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

Review 2.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

Review 3.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 4.  Aetiological diagnosis of ischaemic stroke in young adults.

Authors:  José M Ferro; Ayrton R Massaro; Jean-Louis Mas
Journal:  Lancet Neurol       Date:  2010-11       Impact factor: 44.182

Review 5.  Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Arturo J Martí-Carvajal; Vidhu Anand; Andrés Felipe Cardona; Ivan Solà
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

Review 6.  Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients.

Authors:  Heinrich J Audebert; Johannes Planck; Markus Eisenburg; Hubert Schrezenmeier; Roman L Haberl
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 4.849

7.  Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Anita Hill; Peter Hillmen; Stephen J Richards; Dupe Elebute; Judith C Marsh; Jason Chan; Christopher F Mojcik; Russell P Rother
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 8.  Thrombosis in paroxysmal nocturnal hemoglobinuria.

Authors:  Anita Hill; Richard J Kelly; Peter Hillmen
Journal:  Blood       Date:  2013-04-22       Impact factor: 22.113

9.  Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Claire Hall; Stephen Richards; Peter Hillmen
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

10.  Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Peter Hillmen; Petra Muus; Alexander Röth; Modupe O Elebute; Antonio M Risitano; Hubert Schrezenmeier; Jeffrey Szer; Paul Browne; Jaroslaw P Maciejewski; Jörg Schubert; Alvaro Urbano-Ispizua; Carlos de Castro; Gérard Socié; Robert A Brodsky
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.